Mizuho Issues Pessimistic Forecast for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its target price cut by research analysts at Mizuho from $48.00 to $37.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Mizuho’s price objective points to a potential upside of 27.85% from the stock’s previous close.

Several other research analysts have also recently commented on ACHC. Royal Bank of Canada reduced their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Bank of America reduced their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a report on Friday, February 28th. Barclays cut shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $43.00 to $35.00 in a research note on Friday, February 28th. KeyCorp decreased their price objective on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a report on Monday, March 3rd. Finally, StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $52.19.

Acadia Healthcare Stock Up 0.9 %

ACHC stock opened at $28.94 on Tuesday. The business’s 50-day simple moving average is $38.23 and its 200 day simple moving average is $46.15. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a market cap of $2.69 billion, a PE ratio of 9.49, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. Acadia Healthcare has a twelve month low of $27.61 and a twelve month high of $82.41.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. Lindbrook Capital LLC grew its holdings in shares of Acadia Healthcare by 1,342.0% during the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after purchasing an additional 671 shares during the last quarter. Blue Trust Inc. increased its position in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after acquiring an additional 345 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after purchasing an additional 301 shares during the last quarter. Signaturefd LLC raised its position in Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after purchasing an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp lifted its holdings in Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after buying an additional 454 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.